Develops precision epigenetic medicines targeting adipose biology and cardiometabolic disease using AI-driven epigenetic profiling and engineering.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountJan 2024
Jan 2024
Create a free account to see which investors have funded this company.
Create Free Account
Clinical-stage precision medicine company developing targeted therapies for immune-mediated infla...

China's leading mRNA biotech company developing therapeutics for cancer and infectious diseases.
Biopharmaceutical company developing and commercializing RNAi therapeutics to treat genetically d...

Develops Gene Writing technology and non-viral delivery to create in vivo genetic medicines for m...

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...